Post by
JoeyBoston on Jul 17, 2023 8:03pm
Amyloid Hypothesis gaining strength
Couple of takeaways for me today:
1). With Acumen clinical results, the Amyloid hypothesis continues to be gaining strength (Biogen, Lilly & now Acumen with recent positive clinical results). I think that helps everyone in this ecosystem, including Promis. Increases the likelihood of pharma investing in these companies.
2). Huge volume today, including big volume buys. The question is who are these "investors"? As someone mentioned earlier, were Insiders buying today? Obviously, there will be traders who will be in and out. But, hopefully, we got "new" big investors today who are here for the long-term.
Congrats to Longs.
Comment by
BottomBroker on Jul 17, 2023 8:39pm
Ha, I don't know if congrats are in order just yet. We're back to just below what we were at when PMN hit the NASDAQ. However, today was a pleasant surprise. Just worried about the inevitable slide until the next round of news.
Comment by
M101 on Jul 18, 2023 12:03pm
Yup some slide, but the starting condition is record volume at around US$6 not the day high, so a snap back into last summer's trading pattern. Are those who gave up at $4 or were shorting going to do it again?